Estimates Revisions Bolt Biotherapeutics, Inc.
Stocks
BOLT
US0977022039
Biotechnology & Medical Research
|
Delayed
Nasdaq
16:30:00 2026-08-18 EDT
|
5-day change | 1st Jan Change | ||
| 3.177 USD | -0.71% |
|
-20.17% | -41.89% |
| 08-11 | Bolt Biotherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 05-12 | Bolt Biotherapeutics reports first quarter 2026 financial results | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- BOLT Stock
- Consensus Bolt Biotherapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
